title: Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition.
abstract: BACKGROUND
  There are only few data relating the metabolic consequences of feeding diets very low in n-3 fatty acids. This experiment carried out in mice aims at studying the impact of dietary n-3 polyunsaturated fatty acids (PUFA) depletion on hepatic metabolism.
  
  
  RESULTS
  n-3 PUFA depletion leads to a significant decrease in body weight despite a similar caloric intake or adipose tissue weight. n-3 PUFA depleted mice exhibit hypercholesterolemia (total, HDL, and LDL cholesterol) as well as an increase in hepatic cholesteryl ester and triglycerides content. Fatty acid pattern is profoundly modified in hepatic phospholipids and triglycerides. The decrease in tissue n-3/n-6 PUFA ratio correlates with steatosis. Hepatic mRNA content of key factors involved in lipid metabolism suggest a decreased lipogenesis (SREBP-1c, FAS, PPAR gamma), and an increased beta-oxidation (CPT1, PPAR alpha and PGC1 alpha) without modification of fatty acid esterification (DGAT2, GPAT1), secretion (MTTP) or intracellular transport (L-FABP). Histological analysis reveals alterations of liver morphology, which can not be explained by inflammatory or oxidative stress. However, several proteins involved in the unfolded protein response are decreased in depleted mice.
  
  
  CONCLUSIONS
  n-3 PUFA depletion leads to important metabolic alterations in murine liver. Steatosis occurs through a mechanism independent of the shift between beta-oxidation and lipogenesis. Moreover, long term n-3 PUFA depletion decreases the expression of factors involved in the unfolded protein response, suggesting a lower protection against endoplasmic reticulum stress in hepatocytes upon n-3 PUFA deficiency.
authors.affiliation: Unit of Pharmacokinetics, Metabolism, Nutrition and Toxicology, Université catholique de Louvain, Brussels, Belgium. barbara.pachikian@uclouvain.be
authors.forename: B D
authors.initials: BD
authors.lastname: Pachikian
authors.forename: A M
authors.initials: AM
authors.lastname: Neyrinck
authors.forename: P D
authors.initials: PD
authors.lastname: Cani
authors.forename: L
authors.initials: L
authors.lastname: Portois
authors.forename: L
authors.initials: L
authors.lastname: Deldicque
authors.forename: F C
authors.initials: FC
authors.lastname: De Backer
authors.forename: L B
authors.initials: LB
authors.lastname: Bindels
authors.forename: F M
authors.initials: FM
authors.lastname: Sohet
authors.forename: W J
authors.initials: WJ
authors.lastname: Malaisse
authors.forename: M
authors.initials: M
authors.lastname: Francaux
authors.forename: Y A
authors.initials: YA
authors.lastname: Carpentier
authors.forename: N M
authors.initials: NM
authors.lastname: Delzenne
mesh_terms: D000818:Animals; D004041:Dietary Fats / Q000008:administration & dosage / Q000378:metabolism; D015525:Fatty Acids, Omega-3 / Q000097:blood / Q000378:metabolism*; D005234:Fatty Liver / Q000097:blood / Q000209:etiology / Q000378:metabolism*; D005260:Female; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D014018:Tissue Distribution / Q000502:physiology
chemical_list: D004041:Dietary Fats; D015525:Fatty Acids, Omega-3